Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia, with a prevalence of approximately 0.5% in the general population. 1 The incidence of AF is projected to double from 2010 to 2030, by an estimated 2.6 million cases, increasing total prevalence to 12.1 million cases in the United States. 2 This conduction abnormality is associated with thromboembolic events and decreased cardiac function and can potentially reduce the quality of life in some patients with symptomatic atrial fibrillation. 3 As the understanding behind the pathophysiology of AF develops and new techniques for treatment are introduced, echocardiography has become an increasingly useful tool for both determining which therapy is most appropriate and ruling out a cardiac thrombus prior to cardioversion or an ablation procedure. Two specific treatments are currently available, radiofrequency and cryoballoon ablation, both of which create transmural lesions to disrupt the arrhythmogenic foci causing AF. 4 Depending on clinical presentation and echocardiographic assessment, one technique may be preferred over the other; therefore, it is crucial for sonographers to become familiar with each method and better understand the role of sonography in evaluating for an ablation procedure.